¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"structure activity analysis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insertion activity
    »ðÀÔȰµ¿ÀüÀ§
  • insulin-like activity
    Àν¶¸°À¯»çȰ¼ºµµ
  • integrated neural activity
    ÅëÇսŰæÈ°¼º
  • molar activity
    ¸ôȰ¼º
  • mental activity
    Á¤½ÅȰµ¿
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
  • partial agonistic activity
    ºÎºÐÀÛ¿ëÁ¦È°¼º
  • specific activity
    1. ºñ¹æ»ç´É 2. ºñ(Ýï)Ȱ¼ºµµ, °íÀ¯È°¼ºµµ
  • spontaneous activity
    ÀÚ¹ßÀüÀ§
  • sexual activity
    ¼ºÈ°µ¿
  • antigen analysis
    Ç׿øºÐ¼®
  • arterial blood gas analysis
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • activation analysis
    Ȱ¼ºÈ­ºÐ¼®, ¹æ»çÈ­ºÐ¼®
  • age-period cohort analysis
    ¿¬·É±â°£ÄÚȣƮºÐ¼®
  • analysis
    ºÐ¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antibacterial activity
    Ç×±ÕÀÛ¿ë
  • caries activity
    ¿ì½ÄȰµ¿¼º
  • electrical activity
    Àü±âȰµ¿
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
  • helper cell activity
    µµ¿ò¼¼Æ÷´É, Á¶·Â¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÇàÀ§
  • insertion activity
    »ðÀÔȰµ¿ÀüÀ§
  • integrated neural activity
    ÅëÇսŰæÈ°¼º
  • involuntary activity
    ºÒ¼öÀÇȰµ¿
  • mental activity
    Á¤½ÅȰµ¿
  • molar activity
    ¸ôȰ¼º
  • partial agonistic activity
    ºÎºÐÈ¿´ÉȰ¼º
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ(üÀàõöô), Ȱµ¿µµ(üÀÔÑöô), Ȱ¼º(üÀàõ).
  • activity
    ¹æ»ç´É, Ȱ¼ºµµ
  • activity therapist
    Ȱµ¿ ¿ä¹ý»ç
  • activity therapy
    Ȱµ¿¿ä¹ý(¡­èþÛö).
  • activity therapy
    Ȱµ¿ ¿ä¹ý
  • activity, antibacterial
    Ç×±ÕÀÛ¿ë
  • amylase activity
    ¾Æ¹Ð¶óÁ¦-Ȱ¼ºµµ
  • antibacterial activity
    Ç×±ÕÀÛ¿ë(ù÷жíÂéÄ), Ç×±ÕȰ¼º(ù÷жüÀàõ).
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • fusion activity
    À¶ÇÕ´É
  • glucagon activity
    ±Û·çÄ«°ïȰ¼ºµµ.
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÀû ÇàÀ§
  • plasma histaminase activity
    Ç÷ÀåÈ÷½ºÅ¸¹Ì³ª¾ÆÁ¦È°¼ºµµ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diamond structure
    ´ÙÀ̾Ƹóµå±¸Á¶(¡­Ï°ðã).
  • discoid structure
    ¿ø¹Ý±¸Á¶
  • domain structure
    ¿µ¿ª±¸Á¶
  • electron structure
    (¿øÀÚÀÇ) ÀüÀÚ±¸Á¶(¡­ï³í­Ï°ðã).
  • electron structure of atom
    ¿øÀÚÀÇ ÀüÀÚ±¸Á¶.
  • epidermal structure
    Ç¥ÇDZ¸Á¶
  • helical structure
    ³ª¼±±¸Á¶(¡­Ï°ðã).
  • hemochorial structure
    Ç÷¾×À¶¸ð¸·±¸Á¶
  • hemodichorial structure
    Ç÷¾×µÎÃþÀ¶¸ð¸·±¸Á¶
  • hemoglobin structure
    Ç÷»ö¼Ò±¸Á¶
  • hemomonochorial structure
    Ç÷¾×ȬÃþÀ¶¸ð¸·±¸Á¶
  • immunoglobulin structure
    ¸é¿ª±Û·ÎºÒ¸° ±¸Á¶
  • intra-articular structure
    °üÀý¼Ó±¸Á¶¹°
  • molecular, structure
  • monoclinic structure
    ´Ü»ç±¸Á¶(¡­Ï°ðã).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relative specific activity
    »ó´ë ƯÀÌ È°¼ºµµ(ßÓÓß÷åì¶üÀàõÓø)
  • specific activity
    ºñȰ¼º(ÝïüÀàõ)
  • suppressible insulin-like activity
    ¾ï¾Ð °¡´É(åääâʦÒö) Àν¶¸°À¯»çȰ¼º(×¾ÞÄüÀàõ)
  • surface activity
    Ç¥¸éȰ¼º (øúØüüÀàõ)
  • vibrational optical activity
    Áøµ¿ ±¤ÇРȰ¼º(òÉÔÑÎÃùÊ üÀàõ)
  • beta structure
    º£Å¸ ±¸Á¶(ϰðã)
  • bubble structure
    °Åǰ±¸Á¶(ϰðã)
  • chi structure
    Ä«ÀÌ ±¸Á¶(ϰðã)
  • cholesteric structure
    ÄÝ·¹½ºÅ׸¯ ±¸Á¶(ϰðã)
  • cointegrate structure
    °øÅëÇÕ±¸Á¶(Íì÷×ùêϰðã)
  • contributing structure
    "Âü¿©±¸Á¶(óÑæ¨Ï°ðã), (ÔÒ) canonical structure"
  • eye structure
    ´« ±¸Á¶ (ϰðã)
  • fine-structure genetic mapping
    ¹Ì¼¼ ±¸Á¶(Ú°á¬Ï°ðã) À¯ÀüÀÚ ÀÛµµ(ë¶îîí­íÂÓñ)
  • genetic fine structure
    À¯Àü ¹Ì¼¼±¸Á¶(ë¶îîÚ°á¬Ï°ðã)
  • Greek-key structure
    ±×¸®½º¿­¼è ±¸Á¶(ϰðã)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • statistical analysis
    Åë°èÀûºÐ¼®
  • urine analysis
    ¿ä°Ë»ç
  • vector analysis
    ¹éÅͺм®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PAA partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas...
RSA rabbit serum albumin; regular spiking activity; relative specific activity; relative standard accura...
ISA Instrument Society of America; intracarotid sodium amytal; intrinsic simulating activity; intrinsic ...
MEDPAR Medical Provider Analysis and Review; Medicare Provider Analysis and Review
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DLS Dimer Linkage Structure
EXAFS Extended X-Ray Absorption Fine Structure
QSPR Quantitative Structure-Property Relationship
QSRR Quantitative structure retention relationships
SCSA Sperm Chromatin Structure Assay
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mosaic structure
    ¸ðÀÚÀÌÅ© ±¸Á¶
  • neurologic structure
    ½Å°æ ±¸Á¶
  • organomineral structure
    À¯±â ¹«±âÁú ±¸Á¶
  • other facial structure
    ´Ù¸¥ ¾È¸é ±¸Á¶¹°
  • peripheral structure
    ¸»ÃÊ Á¶Á÷
  • quasicrystalline structure
    ÁذáÁ¤ ±¸Á¶
  • retromandibular structure
    ¾ÇÈÄ ±¸Á¶, ÇÏ¾Ç ÈĹæºÎ ±¸Á¶¹°
  • secondary structure
    ÀÌÂ÷ ±¸Á¶
  • somatic structure
    ü¼º ±¸Á¶
  • structure
    ±¸Á¶
  • submandibular structure
    ¾ÇÇÏ ±¸Á¶
  • supralaryngeal structure
    »óÈĵΠ±¸Á¶
  • activity
    Ȱ¼ºµµ, Ȱµ¿µµ
    1. Ȱ¼ºÈ­µÈ »óÅÂ. ¾î¶² È¿°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â ´É·Â. ¾î¶² ÀÛ¿ë ¶Ç´Â ±â´ÉÀÇ ¿¬Àå. 2. ºñÀÌ»óÀûÀÎ ¿ë¾×¿¡¼­ È¿°úÀûÀÎ ³óµµ¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Â ¿­¿ªÇÐÀûÀÎ ¾ç. ¸¸¾à ³óµµ°¡ Ȱµ¿µµ·Î ´ëü µÈ´Ù¸é ÆòÇü»ó¼ö¿¡ °üÇÑ ¹æÁ¤½Ä, ÀüÀ§, »ïÅõ¾Ð, ²ú´Â Á¡ ¿À¸§, ¾î´Â Á¡ ³»¸², Èֹ߼º ¿ëÁúÀÇ Áõ±â¾ÐÀº Èñ¼® ¿ë¾×¿¡¼­ ¸ðµç ³óµµ¿¡ ´ëÇØ °íÁ¤µÈ Á¤È®ÇÑ ¹æÁ¤½ÄÀÇ ±Ù»ç °ªÀ¸·Î ¹Ù²î¾î Áø´Ù. Ȱµ¿µµ´Â ºñÀÌ»óÀûÀÎ °ÍÀ¸·ÎºÎÅÍ ÃøÁ¤µÈ ºÎÇǰ¡ ¾ø´Â ¼ýÀÚ, Ȱµ¿°è¼ö¿Í »ý»ê¹°ÀÇ ³óµµ¿Í °°´Ù.
  • activity index
    Ȱµ¿ Áö¼ö
  • antibacterial activity
    Ç×±Õ ÀÛ¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
drug activity A measure of the physiological response a drug produces. A less active drug produces less response (and visa versa).
(12 Dec 1998)
insulin-like activity A measure of substances, usually in plasma, that exert biologic effects similar to those of insulin in various bioassays; sometimes used as a measure of plasma insulin concentrations; always gives higher values than immunochemical techniques for the measurement of insulin.
(05 Mar 2000)
intrinsic sympathomimetic activity The property of a drug that causes activation of adrenergic receptors so as to produce effects similar to stimulation of the sympathetic nervous system.
(05 Mar 2000)
optical activity The ability of a material to rotate the plane of polarized light.
(09 Oct 1997)
triggered activity One or a series of spontaneously generated heart beats originating from an action potential that produces an after-depolarisation which reaches activation threshold.
(05 Mar 2000)
unit of thyrotrophic activity The activity of an amount of an extract of the anterior lobe of the hypophysis which, given daily for 5 days, will cause the thyroid of a guinea pig (weighing 200 g) to reach a weight of 600 mg.
(05 Mar 2000)
zone of polarizing activity <cell biology> The small group of mesenchyme cells in avian limb buds that is located at the posterior margin of the developing bud and that produces a substance, possibly retinoic acid, that provides positional information to the developing limb bud.
(18 Nov 1997)
brush heap structure Haphazard interlocking of fibrils in a gel or hydrocolloid impression material.
(05 Mar 2000)
gel structure Brush heap structure of fibrils giving firmness to hydrocolloids.
(05 Mar 2000)
genetic fine structure The study of genes on the level of their nucleotide sequences and what happens to their molecular structure at that level.
(09 Oct 1997)
chi structure <molecular biology> The name for the X-shaped structure which forms during the recombination process between two plasmids, or circular pieces, of DNA. The Greek letter chi resembles this structure.
(05 Jan 1998)
group structure The informal or formal organization of a group of people based on a network of personal relationships which is influenced by the size and composition, etc., of the group.
(12 Dec 1998)
molecular structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number and location of chemical bonds.
(12 Dec 1998)
cointegrate structure A structure of DNA produced by the fusion of two replicons, one possessing a transposon.
(05 Mar 2000)
cruciform structure A structure, shaped like a cross, which can form during homologous recombination when inverted base-pair repeats pair with each other on the same strand of DNA instead of with homologous sections on a different strand of DNA.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • analysis
    ºÐÇØ
  • analysis
    ºÐ¼®;ÇØ¼®;ºÐÇØ
  • conformational analysis
    ¹èÁÂ ÇØ¼®
  • content analysis
    ³»¿ë ºÐ¼®
  • critical path analysis (method)
    Å©¸®Æ¼Äà ÆÐ½º ºÐ¼®¹ý(ÇÁ·ÎÁ§Æ®ÀÇ °èȹ.°ü¸®¸¦ °úÇÐÀûÀ¸·Î ÇÏ´Â ¹æ¹ý)
  • dream analysis
    ²Þ ºÐ¼®
  • factor analysis
    ÀÎÀÚ ºÐ¼®
  • harmonic analysis
    Á¶È­ ºÐ¼®;Á¶È­ ÇØ¼®;Á¶ÆÄ ºÐ¼®
  • high analysis
    (ºñ·á°¡)½Ä¹°ÀÇ ÇÊ¿ä ¾çºÐÀÇ 20% ÀÌ»óÀ» ÇÔÀ¯ÇÏ´Â
  • inputoutput analysis
    ÅõÀÔ»êÃâºÐ¼®
  • job analysis
    ÀÛ¾÷ ºÐ¼®
  • market analysis
    ½ÃÀå ºÐ¼®
  • network analysis
    (¼ö)ȸ·Î(¸Á) ÇØ¼®;³×Æ®¿öÅ©ºÐ¼®;(ȸ·Î¸Á ÇØ¼® ¼ö¹ýÀ» ÀÌ¿ëÇÏ¿© ÇÁ·ÎÁ§Æ®ÀÇ °èȹ °ü¸®¸¦ÇÔ
  • neutron activation analysis
    Áß¼ºÀÚ(À¯µµ)¹æ»çÈ­ ºÐ¼®
  • nonstandard analysis
    ÃÊÁØÇؼ®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á